<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has increased in recent years, and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is a recognized risk factor </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux</z:hpo> of acid and/or bile is linked to these conditions and to reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">Inflammatory disorders</z:e> can lead to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> through activation of "prosurvival genes," including cyclooxygenase-2 (COX-2) and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) </plain></SENT>
<SENT sid="3" pm="."><plain>Increased expression of these enzymes has been found in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Polymorphic variants in COX-2 and iNOS genes may be modifiers of risk of these conditions </plain></SENT>
<SENT sid="5" pm="."><plain>In a population-based case-control study, we examined associations of the COX-2 8473 T&gt;C and iNOS Ser(608) Leu (C&gt;T) polymorphisms with risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Genomic DNA was extracted from blood samples collected from cases of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 210), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (n = 212), and reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 230) and <z:mpath ids='MPATH_458'>normal</z:mpath> population controls frequency matched for age and sex (n = 248) </plain></SENT>
<SENT sid="7" pm="."><plain>Polymorphisms were genotyped using TaqMan allelic discrimination assays </plain></SENT>
<SENT sid="8" pm="."><plain>Odds ratios and 95% confidence intervals were obtained from logistic regression models adjusted for potential confounding factors </plain></SENT>
<SENT sid="9" pm="."><plain>The presence of at least one COX-2 8473 C allele was associated with a significantly increased risk of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (adjusted odds ratio, 1.58; 95% confidence interval, 1.04-2.40) </plain></SENT>
<SENT sid="10" pm="."><plain>There was no significant association between this polymorphism and risk of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> or between the iNOS Ser 608 Leu polymorphism and risk of these esophageal conditions </plain></SENT>
<SENT sid="11" pm="."><plain>Our study suggests that the COX-2 8473 C allele is a potential genetic marker for susceptibility to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>